BX Swiss TOP 30 CHF
1.373,23
PKT
+13,12
PKT
+0,96
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.10.21 | Roche Buy | Deutsche Bank AG | |
| 11.10.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.10.21 | Holcim Neutral | JP Morgan Chase & Co. | |
| 11.10.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.10.21 | Holcim Hold | Jefferies & Company Inc. | |
| 08.10.21 | Nestlé Overweight | Barclays Capital | |
| 08.10.21 | Novartis Buy | UBS AG | |
| 07.10.21 | UBS Sector Perform | RBC Capital Markets | |
| 07.10.21 | Novartis Buy | Jefferies & Company Inc. | |
| 07.10.21 | Roche Buy | Jefferies & Company Inc. | |
| 07.10.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.10.21 | UBS Buy | Jefferies & Company Inc. | |
| 07.10.21 | Nestlé Add | Baader Bank | |
| 07.10.21 | Holcim Overweight | Barclays Capital | |
| 06.10.21 | Swiss Re Overweight | Barclays Capital | |
| 05.10.21 | Zurich Insurance Buy | Kepler Cheuvreux | |
| 05.10.21 | UBS Sector Perform | RBC Capital Markets | |
| 05.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.10.21 | Swiss Re Sell | UBS AG | |
| 04.10.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 04.10.21 | Swiss Re Hold | Jefferies & Company Inc. | |
| 01.10.21 | Nestlé Buy | UBS AG | |
| 01.10.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 30.09.21 | Roche Buy | Deutsche Bank AG | |
| 29.09.21 | Roche Neutral | UBS AG | |
| 29.09.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 29.09.21 | UBS Outperform | RBC Capital Markets | |
| 28.09.21 | Givaudan Hold | Deutsche Bank AG | |
| 24.09.21 | UBS Outperform | Credit Suisse Group | |
| 23.09.21 | Roche Neutral | Credit Suisse Group | |
| 21.09.21 | Nestlé Outperform | Bernstein Research | |
| 20.09.21 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 20.09.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 20.09.21 | Givaudan Buy | UBS AG | |
| 20.09.21 | Novartis Sell | Deutsche Bank AG | |
| 20.09.21 | Holcim Neutral | JP Morgan Chase & Co. | |
| 17.09.21 | Novartis Hold | Deutsche Bank AG | |
| 17.09.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 17.09.21 | Swiss Re Sell | UBS AG | |
| 17.09.21 | Holcim Outperform | Credit Suisse Group |